A detailed history of Prosight Management, LP transactions in Haemonetics Corp stock. As of the latest transaction made, Prosight Management, LP holds 65,000 shares of HAE stock, worth $5.35 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares
65,000
Holding current value
$5.35 Million
% of portfolio
1.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $4.71 Million - $5.95 Million
65,000 New
65,000 $5.22 Million
Q4 2021

Feb 14, 2022

SELL
$49.55 - $74.59 $1.9 Million - $2.86 Million
-38,319 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$57.6 - $70.59 $5.51 Million - $6.75 Million
-95,681 Reduced 71.4%
38,319 $2.71 Million
Q2 2021

Aug 13, 2021

BUY
$51.81 - $118.56 $6.94 Million - $15.9 Million
134,000 New
134,000 $8.93 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.22B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.